HEADER HYDROLASE 30-AUG-17 5OVX TITLE X-RAY CHARACTERIZATION OF STRIATAL-ENRICHED PROTEIN TYROSINE TITLE 2 PHOSPHATASE INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 5; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: NEURAL-SPECIFIC PROTEIN-TYROSINE PHOSPHATASE,STRIATUM- COMPND 5 ENRICHED PROTEIN-TYROSINE PHOSPHATASE,STEP; COMPND 6 EC: 3.1.3.48; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PTPN5; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PHOSPHATASE, ALZHEIMER'S DISEASE, INHIBITOR, PTPN5, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR H.KACK,L.WISSLER REVDAT 3 17-JAN-24 5OVX 1 REMARK REVDAT 2 29-NOV-17 5OVX 1 JRNL REVDAT 1 22-NOV-17 5OVX 0 JRNL AUTH M.R.WITTEN,L.WISSLER,M.SNOW,S.GESCHWINDNER,J.A.READ, JRNL AUTH 2 N.J.BRANDON,A.C.NAIRN,P.J.LOMBROSO,H.KACK,J.A.ELLMAN JRNL TITL X-RAY CHARACTERIZATION AND STRUCTURE-BASED OPTIMIZATION OF JRNL TITL 2 STRIATAL-ENRICHED PROTEIN TYROSINE PHOSPHATASE INHIBITORS. JRNL REF J. MED. CHEM. V. 60 9299 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 29116812 JRNL DOI 10.1021/ACS.JMEDCHEM.7B01292 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 21.85 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 20246 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.120 REMARK 3 FREE R VALUE TEST SET COUNT : 1036 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.21 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.90 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2910 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1789 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2746 REMARK 3 BIN R VALUE (WORKING SET) : 0.1750 REMARK 3 BIN FREE R VALUE : 0.2494 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.64 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 164 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2330 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 252 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.20550 REMARK 3 B22 (A**2) : 1.83490 REMARK 3 B33 (A**2) : 0.37060 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.242 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.238 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.179 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.212 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.172 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.919 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.902 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2429 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3306 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 837 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 66 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 354 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2429 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 312 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2910 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.04 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.39 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.05 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 14.6880 -5.0950 -15.7047 REMARK 3 T TENSOR REMARK 3 T11: -0.0524 T22: -0.1022 REMARK 3 T33: -0.0489 T12: 0.0143 REMARK 3 T13: 0.0239 T23: 0.0219 REMARK 3 L TENSOR REMARK 3 L11: 1.2618 L22: 1.0996 REMARK 3 L33: 1.9268 L12: -0.0386 REMARK 3 L13: -0.7274 L23: -0.2748 REMARK 3 S TENSOR REMARK 3 S11: 0.0401 S12: 0.0093 S13: -0.0138 REMARK 3 S21: 0.0146 S22: 0.0247 S23: 0.1581 REMARK 3 S31: -0.0824 S32: -0.1573 S33: -0.0648 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5OVX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-AUG-17. REMARK 100 THE DEPOSITION ID IS D_1200006449. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-OCT-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN A200 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.2.8 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20322 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 100.340 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : 0.10200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.16 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.00 REMARK 200 R MERGE FOR SHELL (I) : 0.51100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2BV5 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 26-28% PEG3350, 0.1M BIS-TRIS PH5.5, REMARK 280 0.2M LITHIUM SULFATE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.05850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 50.16900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.06200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 50.16900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.05850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 32.06200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 235 REMARK 465 HIS A 236 REMARK 465 HIS A 237 REMARK 465 HIS A 238 REMARK 465 HIS A 239 REMARK 465 HIS A 240 REMARK 465 HIS A 241 REMARK 465 SER A 242 REMARK 465 SER A 243 REMARK 465 GLY A 244 REMARK 465 VAL A 245 REMARK 465 ASP A 246 REMARK 465 LEU A 247 REMARK 465 GLY A 248 REMARK 465 THR A 249 REMARK 465 GLU A 250 REMARK 465 GLN A 538 REMARK 465 SER A 539 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 293 69.44 -113.25 REMARK 500 ILE A 374 76.48 -112.06 REMARK 500 MET A 380 -3.14 -57.22 REMARK 500 ASN A 381 -87.77 -74.33 REMARK 500 GLU A 391 -58.32 -132.06 REMARK 500 SER A 473 -70.06 -37.85 REMARK 500 ILE A 476 -44.23 -134.25 REMARK 500 ILE A 515 85.74 73.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 952 DISTANCE = 6.01 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue AY5 A 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5OVR RELATED DB: PDB DBREF 5OVX A 258 539 UNP P54829 PTN5_HUMAN 258 539 SEQADV 5OVX MET A 235 UNP P54829 INITIATING METHIONINE SEQADV 5OVX HIS A 236 UNP P54829 EXPRESSION TAG SEQADV 5OVX HIS A 237 UNP P54829 EXPRESSION TAG SEQADV 5OVX HIS A 238 UNP P54829 EXPRESSION TAG SEQADV 5OVX HIS A 239 UNP P54829 EXPRESSION TAG SEQADV 5OVX HIS A 240 UNP P54829 EXPRESSION TAG SEQADV 5OVX HIS A 241 UNP P54829 EXPRESSION TAG SEQADV 5OVX SER A 242 UNP P54829 EXPRESSION TAG SEQADV 5OVX SER A 243 UNP P54829 EXPRESSION TAG SEQADV 5OVX GLY A 244 UNP P54829 EXPRESSION TAG SEQADV 5OVX VAL A 245 UNP P54829 EXPRESSION TAG SEQADV 5OVX ASP A 246 UNP P54829 EXPRESSION TAG SEQADV 5OVX LEU A 247 UNP P54829 EXPRESSION TAG SEQADV 5OVX GLY A 248 UNP P54829 EXPRESSION TAG SEQADV 5OVX THR A 249 UNP P54829 EXPRESSION TAG SEQADV 5OVX GLU A 250 UNP P54829 EXPRESSION TAG SEQADV 5OVX ASN A 251 UNP P54829 EXPRESSION TAG SEQADV 5OVX LEU A 252 UNP P54829 EXPRESSION TAG SEQADV 5OVX TYR A 253 UNP P54829 EXPRESSION TAG SEQADV 5OVX PHE A 254 UNP P54829 EXPRESSION TAG SEQADV 5OVX GLN A 255 UNP P54829 EXPRESSION TAG SEQADV 5OVX SER A 256 UNP P54829 EXPRESSION TAG SEQADV 5OVX MET A 257 UNP P54829 EXPRESSION TAG SEQRES 1 A 305 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 305 GLY THR GLU ASN LEU TYR PHE GLN SER MET SER ARG VAL SEQRES 3 A 305 LEU GLN ALA GLU GLU LEU HIS GLU LYS ALA LEU ASP PRO SEQRES 4 A 305 PHE LEU LEU GLN ALA GLU PHE PHE GLU ILE PRO MET ASN SEQRES 5 A 305 PHE VAL ASP PRO LYS GLU TYR ASP ILE PRO GLY LEU VAL SEQRES 6 A 305 ARG LYS ASN ARG TYR LYS THR ILE LEU PRO ASN PRO HIS SEQRES 7 A 305 SER ARG VAL CYS LEU THR SER PRO ASP PRO ASP ASP PRO SEQRES 8 A 305 LEU SER SER TYR ILE ASN ALA ASN TYR ILE ARG GLY TYR SEQRES 9 A 305 GLY GLY GLU GLU LYS VAL TYR ILE ALA THR GLN GLY PRO SEQRES 10 A 305 ILE VAL SER THR VAL ALA ASP PHE TRP ARG MET VAL TRP SEQRES 11 A 305 GLN GLU HIS THR PRO ILE ILE VAL MET ILE THR ASN ILE SEQRES 12 A 305 GLU GLU MET ASN GLU LYS CYS THR GLU TYR TRP PRO GLU SEQRES 13 A 305 GLU GLN VAL ALA TYR ASP GLY VAL GLU ILE THR VAL GLN SEQRES 14 A 305 LYS VAL ILE HIS THR GLU ASP TYR ARG LEU ARG LEU ILE SEQRES 15 A 305 SER LEU LYS SER GLY THR GLU GLU ARG GLY LEU LYS HIS SEQRES 16 A 305 TYR TRP PHE THR SER TRP PRO ASP GLN LYS THR PRO ASP SEQRES 17 A 305 ARG ALA PRO PRO LEU LEU HIS LEU VAL ARG GLU VAL GLU SEQRES 18 A 305 GLU ALA ALA GLN GLN GLU GLY PRO HIS CYS ALA PRO ILE SEQRES 19 A 305 ILE VAL HIS CYS SER ALA GLY ILE GLY ARG THR GLY CYS SEQRES 20 A 305 PHE ILE ALA THR SER ILE CYS CYS GLN GLN LEU ARG GLN SEQRES 21 A 305 GLU GLY VAL VAL ASP ILE LEU LYS THR THR CYS GLN LEU SEQRES 22 A 305 ARG GLN ASP ARG GLY GLY MET ILE GLN THR CSO GLU GLN SEQRES 23 A 305 TYR GLN PHE VAL HIS HIS VAL MET SER LEU TYR GLU LYS SEQRES 24 A 305 GLN LEU SER HIS GLN SER MODRES 5OVX CSO A 518 CYS MODIFIED RESIDUE HET CSO A 518 7 HET AY5 A 601 28 HETNAM CSO S-HYDROXYCYSTEINE HETNAM AY5 [(~{S})-[4-[3-[(~{S})-(3,4-DICHLOROPHENYL)-OXIDANYL- HETNAM 2 AY5 METHYL]PHENYL]PHENYL]-OXIDANYL-METHYL]PHOSPHONIC ACID FORMUL 1 CSO C3 H7 N O3 S FORMUL 2 AY5 C20 H17 CL2 O5 P FORMUL 3 HOH *252(H2 O) HELIX 1 AA1 GLN A 262 LEU A 271 1 10 HELIX 2 AA2 ASP A 272 PHE A 281 1 10 HELIX 3 AA3 ASP A 289 ASP A 294 5 6 HELIX 4 AA4 GLY A 297 ASN A 302 5 6 HELIX 5 AA5 ASN A 310 HIS A 312 5 3 HELIX 6 AA6 GLY A 337 GLU A 341 5 5 HELIX 7 AA7 ILE A 352 SER A 354 5 3 HELIX 8 AA8 THR A 355 HIS A 367 1 13 HELIX 9 AA9 ASN A 376 MET A 380 5 5 HELIX 10 AB1 THR A 440 ASP A 442 5 3 HELIX 11 AB2 ARG A 443 GLU A 461 1 19 HELIX 12 AB3 ILE A 476 GLY A 496 1 21 HELIX 13 AB4 ASP A 499 ARG A 511 1 13 HELIX 14 AB5 THR A 517 SER A 536 1 20 SHEET 1 AA1 9 ARG A 314 CYS A 316 0 SHEET 2 AA1 9 TYR A 329 ILE A 335 -1 O ALA A 332 N VAL A 315 SHEET 3 AA1 9 TYR A 345 GLN A 349 -1 O TYR A 345 N ILE A 335 SHEET 4 AA1 9 ILE A 468 CYS A 472 1 O VAL A 470 N ILE A 346 SHEET 5 AA1 9 ILE A 370 ILE A 374 1 N ILE A 374 O HIS A 471 SHEET 6 AA1 9 GLU A 423 PHE A 432 1 O TYR A 430 N MET A 373 SHEET 7 AA1 9 TYR A 411 SER A 420 -1 N ILE A 416 O LEU A 427 SHEET 8 AA1 9 VAL A 398 HIS A 407 -1 N GLU A 399 O LYS A 419 SHEET 9 AA1 9 GLN A 392 TYR A 395 -1 N VAL A 393 O ILE A 400 LINK C THR A 517 N CSO A 518 1555 1555 1.34 LINK C CSO A 518 N GLU A 519 1555 1555 1.36 CISPEP 1 SER A 319 PRO A 320 0 3.75 SITE 1 AC1 15 ASN A 376 GLU A 378 GLU A 379 LYS A 404 SITE 2 AC1 15 SER A 434 TRP A 435 PRO A 436 ASP A 437 SITE 3 AC1 15 LYS A 439 ARG A 443 ARG A 478 GLN A 520 SITE 4 AC1 15 HOH A 703 HOH A 828 HOH A 858 CRYST1 52.117 64.124 100.338 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019188 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015595 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009966 0.00000